1Department of Internal Medicine, Division of Cardiovascular Medicine, Department of Public Health Sciences, Division of Biostatistics
2University of California Davis, Sacramento, CA, Advanced Heart Failure and Transplant Cardiology, University of North Carolina
3Chapel Hill, NC, Department of Public Health, Texas Tech University Health Sciences Center
4Lubbock, TX, Division of Cardiovascular Medicine, University of Chicago
5Chicago, Center for Cardiovascular Disease Prevention, Baylor College of Medicine
6Houston, TX, Division of Public Health Sciences, Wake Forest University School of Medicine
7Winston Salem, NC.
Address correspondence to: Imo A. Ebong, MD, MS, Division of Cardiology, University of California Davis, 4860 Y Street, Suite 2860, Sacramento, CA 95817. E-mail: [email protected]
Received 14 August, 2021
Revised 30 September, 2021
Accepted 30 September, 2021
Funding/support: The Atherosclerosis Risk in Communities study has been funded in whole or in part with federal funds from the National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services, under Contract nos. (HHSN268201700001I, HHSN268201700002I, HHSN268201700003I, HHSN268201700005I, and HHSN268201700004I).
M. W. is supported by the National Center for Advancing Translational Sciences, National Institutes of Health, through grant number UL1 TR001860.
C. B. has received support from the National Institutes of Health grant R01 HL134320.
Financial disclosure/conflicts of interest: C. B. has received grant/research support (to his institution) from Abbott Diagnostic, Akcea, Amgen, Esperion, Ionis, Novartis, Regeneron, and Roche Diagnostic, and has been a consultant for Abbott Diagnostics, Althera, Amarin, Amgen, Arrowhead, AstraZeneca, Corvidia, Denka Seiken, Esperion, Genentech, Gilead, Matinas BioPharma Inc, New Amsterdam, Novartis, Novo Nordisk, Pfizer, Regeneron, Roche Diagnostic, and Sanofi-Synthelabo. A. G. B. has received funding from the National Institute of Health. The other authors have nothing to disclose.
Supplemental digital content is available for this article. Direct URL citations are provided in the HTML and PDF versions of this article on the journal's Website (www.menopause.org).
